Icon Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $277K | Hold |
336
| – | – | 0.03% | 246 |
|
|
2023
Q2 | $241K | Buy |
336
+6
| +2% | +$4.31K | 0.03% | 290 |
|
|
2023
Q1 | $271K | Buy |
+330
| New | +$271K | 0.03% | 266 |
|
|
2022
Q2 | $229K | Sell |
387
-64
| -14% | -$37.9K | 0.03% | 278 |
|
|
2022
Q1 | $315K | Sell |
451
-12
| -3% | -$8.38K | 0.03% | 263 |
|
|
2021
Q4 | $292K | Sell |
463
-6
| -1% | -$3.78K | 0.03% | 264 |
|
|
2021
Q3 | $284K | Sell |
469
-2
| -0.4% | -$1.21K | 0.03% | 287 |
|
|
2021
Q2 | $263K | Sell |
471
-6
| -1% | -$3.35K | 0.03% | 316 |
|
|
2021
Q1 | $226K | Sell |
477
-2,902
| -86% | -$1.37M | 0.03% | 308 |
|
|
2020
Q4 | $1.63M | Buy |
3,379
+618
| +22% | +$298K | 0.26% | 86 |
|
|
2020
Q3 | $1.55M | Buy |
2,761
+2,095
| +315% | +$1.17M | 0.3% | 83 |
|
|
2020
Q2 | $415K | Buy |
666
+7
| +1% | +$4.36K | 0.1% | 144 |
|
|
2020
Q1 | $322K | Buy |
659
+24
| +4% | +$11.7K | 0.13% | 94 |
|
|
2019
Q4 | $238K | Buy |
+635
| New | +$238K | 0.08% | 149 |
|
|
2019
Q2 | – | Sell |
-344
| Closed | -$141K | – | 627 |
|
|
2019
Q1 | $141K | Buy |
344
+30
| +10% | +$12.3K | 0.05% | 183 |
|
|
2018
Q4 | $117K | Sell |
314
-14
| -4% | -$5.22K | 0.06% | 196 |
|
|
2018
Q3 | $133K | Buy |
328
+4
| +1% | +$1.62K | 0.06% | 221 |
|
|
2018
Q2 | $112K | Buy |
+324
| New | +$112K | 0.05% | 221 |
|
|
2018
Q1 | – | Sell |
-206
| Closed | -$77K | – | 625 |
|
|
2017
Q4 | $77K | Buy |
+206
| New | +$77K | 0.04% | 320 |
|